Open Questions Known risks: clinical, competitive, regulatory, reimbursement, IP, financial, commercial, pricing Assumptions GLP-1 sales for 2023 were approximately $29 billion and it is estimated that 30% of prescriptions could not be filled due to shortages
Emerging evidence now shows addiction isnt exclusively a disorder of synapses and dopamine
Adrian stocked up on three months of compounded tirzepatide, but he worried that the FDA would shut down his provider before he could afford to stockpile more medication
Lysates were cleared twice by centrifugation (12,000g, 10 minutes), and the total protein concentration was measured by Direct Detect Spectrophotometer (Millipore)
do not wait for scheduled follow-up
Cell Metab 17(6):819837